Iran nuclear deal 'in sight' as talks resume
Canada province lifts all Covid restrictions amid protests
At least 11 dead in Colombia mudslide
Johnson & Johnson temporarily halts Covid-19 vaccine output: report
Canadian anti-vax truckers inspire copycat protests
Podcaster Joe Rogan has been offered a deal similar to his Spotify deal, although this deal claims it will not censor any of his content.
Pfizer sees Covid-19 drug sales topping $50 bn in 2022
iPhones to work as digital payment points in US
African migrants face racism, violence in Brazil
Hyundai and Kia are urging vehicle owners to park their cars outdoors due to the potential for a fire to break out even when not running.
Neil Young urges Spotify employees to quit
Slumping Peloton replaces CEO, cuts 2,800 jobs
Telenor Myanmar sale challenged over data leak fears
The steering component removal affected some Tesla Model 3 and Model Y cars.
India riled after big brands back Kashmir on social media
Australian model, entrepreneur and social media star Harry Jowsey has a net worth of $4.5 million.
Pfizer's 2021 profits doubled to $22 bn on strong Covid vaccine sales
The mansion will be auctioned off with a guide price of just $530,000 — less than the price of a one-bedroom flat in London.
Venice glassblowers scorched by blazing energy bills
Taiwan eases nuclear-accident food import ban from Japan
SoftBank's $40 bn sale of chip group Arm to Nvidia collapses
Australia PM apologises for abuse, bullying in parliament
American lawyer jailed again for assaulting Hong Kong police
Chinese drug giant halts trading as US move triggers stock plunge
Hong Kongers picnic to avoid Covid-tracing app
China's Gu strikes freeski Big Air gold at Beijing Olympics
Oil prices fall as tensions ease, stocks mostly advance
EU leaders vow unity as Macron sees path on easing Russia tensions
EU joins chips race with 43-bn-euro bid to rival Asia
Japan's SoftBank Group announced in 2020 that it was selling Arm for up to $40 billion in a deal it hoped to complete in early 2022, subject to regulatory approvals.